|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocn801404391 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
120723s2008 enka ob 001 0 eng d |
010 |
|
|
|z 2008021573
|
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d OCLCQ
|d OCLCF
|d NLGGC
|d YDXCP
|d EBLCP
|d IDEBK
|d OCLCQ
|d STBDS
|d TOA
|d AGLDB
|d OCLCO
|d OCLCQ
|d OCLCA
|d STF
|d OCLCO
|d VNS
|d VTS
|d REC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d AJS
|d OCLCQ
|d OCLCO
|d INARC
|d OCLCO
|d OCLCQ
|
015 |
|
|
|a GBA889279
|2 bnb
|
016 |
7 |
|
|a 101474374
|2 DNLM
|
016 |
7 |
|
|a 014669623
|2 Uk
|
019 |
|
|
|a 801363524
|a 1302077418
|
020 |
|
|
|a 9780191564628
|q (electronic bk.)
|
020 |
|
|
|a 0191564621
|q (electronic bk.)
|
020 |
|
|
|z 9780199552764
|
020 |
|
|
|z 0199552762
|
029 |
1 |
|
|a AU@
|b 000051583918
|
029 |
1 |
|
|a AU@
|b 000062594391
|
029 |
1 |
|
|a DEBBG
|b BV043157840
|
029 |
1 |
|
|a DEBSZ
|b 421394722
|
035 |
|
|
|a (OCoLC)801404391
|z (OCoLC)801363524
|z (OCoLC)1302077418
|
050 |
|
4 |
|a RC392
|b .I558 2008eb
|
060 |
|
4 |
|a W1
|b FR945YD v.16 2008
|
060 |
|
4 |
|a WL 342
|b I58 2008
|
072 |
|
7 |
|a HEA
|x 039110
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 056000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8/491061
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Innovative drug development for headache disorders /
|c edited by Jes Olesen, Nabih Ramadan.
|
260 |
|
|
|a Oxford ;
|a New York :
|b Oxford University Press,
|c 2008.
|
300 |
|
|
|a 1 online resource (xii, 227 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Frontiers in headache research series ;
|v v. 16
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Effectiveness of different steroid dosage in Tolosa-Hunt syndrome with different phenotypes: some critical points about the new International Headache Society classification / E. Marchioni [and others] -- Discussion summary: trial methodology / Jes Olesen -- Inducible nitric oxide synthase and development of new migraine treatments / Boris A. Chizh -- Mechanisms of cortical spreading depression as targets for migraine therapy / Kevin C. Brennan and Andrew C. Charles -- Tonabersat / Peter R. Blower and Paul C. Sharpe -- Discussion summary: nitric oxide and spreading depression modulators / Nabih Ramadan -- Calcitonin gene-related peptide: relevance for migraine / Jes Olesen and Inger Jansen-Olesen.
|
505 |
0 |
|
|a KATP channels and migraine / Inger Jansen-Olesen and Kenneth Beri Ploug -- Antiepileptic drugs and migraine / Michael A. Rogawski -- Discussion summary : ion channel modulators and antiepileptics / Pramod R. Saxena -- Innovative drug development for headache disorders : glutamate / Kirk W. Johnson [and others] -- The modulation of TRPV1 channels by cannabinoid1 receptors / Beatriz Fioravanti and Todd W. Vanderah -- Future targets for headache therapy: prostanoids / Christian Waeber -- Role of anandamide in the modulation of nitroglycerin-induced hyperalgesia: a study in the rat / Cristina Tassorelli [and others].
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans, it was widely presumed that migraine was no longer a treatment problem. However, it has gradually been recognized that a significant proportion of patients are not responsive to triptans or do not tolerate them.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Headache
|x Chemotherapy.
|
650 |
|
0 |
|a Analgesics.
|
650 |
|
0 |
|a Drug development.
|
650 |
1 |
2 |
|a Headache Disorders
|x drug therapy
|
650 |
2 |
2 |
|a Headache Disorders
|x prevention & control
|
650 |
|
2 |
|a Analgesics
|
650 |
|
6 |
|a Céphalée
|x Chimiothérapie.
|
650 |
|
6 |
|a Analgésiques.
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Nervous System (incl. Brain)
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Neurology.
|2 bisacsh
|
650 |
|
7 |
|a Analgesics.
|2 fast
|0 (OCoLC)fst00808271
|
650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
650 |
|
7 |
|a Headache
|x Chemotherapy.
|2 fast
|0 (OCoLC)fst00952647
|
650 |
1 |
7 |
|a Céphalées
|x traitement médicamenteux.
|2 fmesh
|
650 |
2 |
7 |
|a Céphalées
|x prévention et contrôle.
|2 fmesh
|
650 |
|
7 |
|a Migraine
|x Chimiothérapie.
|2 ram
|
650 |
|
7 |
|a Analgésiques.
|2 ram
|
700 |
1 |
|
|a Olesen, Jes.
|
700 |
1 |
|
|a Ramadan, Nabih.
|
776 |
0 |
8 |
|i Print version:
|t Innovative drug development for headache disorders.
|d Oxford ; New York : Oxford University Press, 2008
|z 9780199552764
|w (DLC) 2008021573
|w (OCoLC)228569514
|
830 |
|
0 |
|a Frontiers in headache research ;
|v v. 16.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467641
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL975568
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10581488
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 467641
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 389289
|
938 |
|
|
|a Oxford University Press USA
|b OUPR
|n EDZ0000128737
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 9316015
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12890334
|
938 |
|
|
|a Internet Archive
|b INAR
|n innovativedrugde0000unse
|
994 |
|
|
|a 92
|b IZTAP
|